| Saul P Greenfield, MD | |
|
219 Bryant Street, Buffalo, NY 14222 | |
| (716) 878-7393 | |
| (716) 878-7096 |
| Full Name | Saul P Greenfield |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 219 Bryant Street, Buffalo, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730153909 | NPI | - | NPPES |
| 00830460 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 141541 (New York) | Primary |
| Entity Name | Ezras Choilim Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063480218 PECOS PAC ID: 6406747989 Enrollment ID: O20040323001580 |
News Archive
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
Induced pluripotent stem cells hold promise for regenerative medicine because they can, in theory, turn into any type of tissue and because they are made from a patient's own adult cells, guaranteeing compatibility. However, the technique that turns adult cells into these iPS cells is not foolproof; after reverting to their pluripotent state, these cells don't always correctly differentiate back into adult cells.
› Verified 8 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
Induced pluripotent stem cells hold promise for regenerative medicine because they can, in theory, turn into any type of tissue and because they are made from a patient's own adult cells, guaranteeing compatibility. However, the technique that turns adult cells into these iPS cells is not foolproof; after reverting to their pluripotent state, these cells don't always correctly differentiate back into adult cells.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Saul P Greenfield, MD 219 Bryant Street, Buffalo, NY 14222 Ph: (716) 878-7393 | Saul P Greenfield, MD 219 Bryant Street, Buffalo, NY 14222 Ph: (716) 878-7393 |
News Archive
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).
Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
Induced pluripotent stem cells hold promise for regenerative medicine because they can, in theory, turn into any type of tissue and because they are made from a patient's own adult cells, guaranteeing compatibility. However, the technique that turns adult cells into these iPS cells is not foolproof; after reverting to their pluripotent state, these cells don't always correctly differentiate back into adult cells.
› Verified 8 days ago
Dr. Ezekiel Young, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1001 Main St, Buffalo, NY 14203 Phone: 716-859-7978 Fax: 716-859-1275 | |
Naif Abdullah Aldhaam, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 665 Elm St, Buffalo, NY 14203 Phone: 716-845-3389 | |
Ali Ahmad Ishaq Al-daghmin, Urology Medicare: Not Enrolled in Medicare Practice Location: Elm And Carlton St, Cell And Virus Building 216, Buffalo, NY 14263 Phone: 716-845-8813 | |
Roshan Navaratnam, Urology Medicare: Not Enrolled in Medicare Practice Location: 665 Elm St, Buffalo, NY 14203 Phone: 716-845-3389 | |
James Lloyd Mohler, MD Urology Medicare: Not Enrolled in Medicare Practice Location: Elm And Carlton St, Buffalo, NY 14263 Phone: 716-845-2300 Fax: 716-845-3300 | |
Abd El-hamid Khairy, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 21 Spindrift Ct Apt 6, Buffalo, NY 14221 Phone: 269-359-6920 | |
Ahmad Zakaria Mohamed, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1001 Main St, Buffalo, NY 14203 Phone: 716-859-7978 Fax: 716-859-1295 |